EPO Patents = 4

Forward Citations = 2

Loading Chart...

7 inventors (with patents filed for the assignee):

Tong-Ho Lin (5 out of 6 patents)

Yung-Shun Wen (5 out of 5 patents)

Jui-Wei Liang (3 out of 3 patents)

4. Wei-Ju Chang (1 out of 1 patent)

5. Chia-Hsien Chen (1 out of 1 patent)

6. Zhi-Rong Wu (1 out of 1 patent)

7. Ying-Ting Liu (1 out of 1 patent)

8. Rui-Zhi Hou (0 patent)

9. Chia-Hsien Chen (0 patent)

10. Chia-Hsien Chen (0 patent)

5 patents: Sort by Forward Citations

1. 12522610 - Long-acting injectable formulations and crystalline forms of buprenorphine derivatives (2026-01-13),

2. 12201630 - Naltrexone injectable sustained release formulation (2025-01-21),

3. 11981617 - Ketamine pamoate and use thereof (2024-05-14),

4. 11524965 - Long-acting injectable formulations and crystalline forms of buprenorphine derivatives (2022-12-13),

5. 10744132 - Sustained-release buprenorphine formulations (2020-08-18),

Company Overview

Alar Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of serious diseases. The company specializes in creating novel drug formulations and delivery systems aimed at improving patient outcomes. With a commitment to research and development, Alar Pharmaceuticals collaborates with leading academic institutions and industry partners to advance its pipeline of therapeutic candidates. The company's mission is to address unmet medical needs through cutting-edge science and technology, ultimately enhancing the quality of life for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#778 in Taipei

#2,367 in Taiwan

Taipei, Taiwan

Alar Pharmaceuticals, Inc.

Forward Citations = 2

7 inventors:

Tong-Ho Lin (5 out of 6 patents)

Yung-Shun Wen (5 out of 5 patents)

Jui-Wei Liang (3 out of 3 patents)

4. Wei-Ju Chang (1 out of 1 patent)

5. Chia-Hsien Chen (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alar Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/alar-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]